Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

530 trials

NCT06805773
Recruiting
Evaluating the Use of Educational Videos in Newly Diagnosed Patients in a Medical Oncology Sarcoma Clinic
Not applicable · Canada · 1 site
Registry update: 14 Oct 2026
NCT06975293
Recruiting
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
Phase 1/2 · United States · 14 sites
Registry update: 22 Oct 2026
NCT07315542
Recruiting
Diagnostic and Therapeutic Targets in Cartilaginous Tumours
Not applicable · Czechia · 1 site
Registry update: 5 Jan 2026
NCT06715579
Recruiting
Cardiac Angiosarcoma International Registry
Not applicable · Armenia · 1 site
Registry update: 18 Feb 2026
NCT07064018
Recruiting
Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies
Phase 1/2 · United States · 1 site
Registry update: 17 Jul 2026
NCT06884618
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
Phase 1 · Australia, Canada, China, Denmark, Spain, United Kingdom, Hong Kong, New Zealand, Singapore, Taiwan, United States · 25 sites
Registry update: 28 Sept 2026
NCT07067255
Recruiting
Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer
Phase 1/2 · China · 1 site
Registry update: 16 Jul 2025
NCT06710756
Recruiting
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Phase 1/2 · United States · 16 sites
Registry update: 28 Oct 2026
NCT06962072
Recruiting
Outcomes Following Limb Sparing Surgery for Soft Tissue Sarcoma
Not applicable · Netherlands · 1 site
Registry update: 19 Dec 2025
2024-515245-42-00
Recruiting
International open-label phase I dose escalation study of dinutuximab beta in combination with vincristine/doxorubicin/cyclophosphamide and ifosfamide/etoposide in pediatric, adolescent, and adult patients with GD2-positive Ewing sarcoma
Phase 1 · Austria, Czechia, Germany, Sweden · 14 sites
Registry update: 8 Jul 2026
NCT06943521
Recruiting
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Phase 1/2 · Japan, United States · 6 sites
Registry update: 11 Dec 2025
NCT06881992
Recruiting
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Phase 3 · Switzerland, France, United Kingdom, Netherlands, United States · 13 sites
Registry update: 28 Sept 2026
NCT06332274
Recruiting
tislelizUMaB in canceR Patients With molEcuLar residuaL Disease
Phase 3 · France · 1 site
Registry update: 13 May 2025
NCT06827717
Recruiting
Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma
Phase 2 · China · 1 site
Registry update: 31 May 2025
NCT06892678
Recruiting
DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma
Phase 1/2 · United States · 1 site
Registry update: 14 May 2026
NCT06610682
Recruiting
A Trial to Evaluate CSF ctDNA and Safety of Plixorafenib Alone or With Retifanlimab in Patients With BRAF-altered Glioma
Early phase 1 · United States · 2 sites
Registry update: 22 Sept 2026
NCT07675967
Recruiting
Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
Not applicable · United States · 1 site
Registry update: 30 Jun 2026
NCT06905132
Recruiting
Preoperative 5-Day Radiotherapy for Soft Tissue Sarcoma
Phase 2 · United States · 1 site
Registry update: 30 Mar 2026
NCT06840886
Recruiting
A Study of PHST001 in Advanced Solid Tumors
Phase 1 · United States · 20 sites
Registry update: 5 Oct 2026
NCT06700070
Recruiting
A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors
Early phase 1 · United States · 1 site
Registry update: 11 Aug 2025

Ordered by registry start date. Freshness and sponsorship never change the order.